Opinion: Why you'll be hearing more about cannabis, bud
OPINION: Mark Dye explains why dried cannabis flowers will a hot topic in the near future.
AdvertisementAdvertise with NZME.
Latest fromPharmaceuticals
Watch: Experts explain 'gamechanger' treatments for Covid
They've been described as "gamechangers" in the fight against Covid-19.
Pfizer says booster protects against Omicron
Pharma claims booster increases people's levels of antibodies by 25-fold.
'Damning' Pharmac report reveals 'fortress mentality' to decision-making
It also questions commitments to equity; just four of its nearly 150 staff are Māori.
First wahine Māori to head Pharmac advisory board
Dr Jane Thomas to lead Pharmacology and Therapeutics Advisory Committee from December.
AFT Pharmaceuticals signals future dividend as revenue, profits improve
The company will consider a dividend policy once it meets a net debt target.
Pfizer releases anti-viral pill to other makers
Health officials hope the deal could help to end the pandemic sooner.
Opinion | Give Kiwis with cystic fibrosis a future
OPINION: Christine Perrins puts the case for Pharmac to fund a life-changing treatment.
Pfizer asks US to approve vaccine for ages 5-11
Plan to ship lower-dose vials, especially marked for use in children.
Manukau supermarket among latest Auckland locations of interest
People who were at this location must isolate and get tested immediately, authorities say.
Meet Fifi, the llama whose antibodies could hold the key to fighting Covid
Coronavirus treatment made from llama nanobodies 'one of the most effective ever tested'.
Opinion | Your 'free' jab will save lives
OPINION: Graeme Jarvis writes vaccine development is more expensive than rocket science.
Opinion | How 'free' Covid jabs are making the mega-rich richer
OPINION: Nations paying between 4 and 24 times more than the cost of producing vaccines.
Opinion | The value of a New Zealander's life
OPINION: Why is a life saved from Covid-19 worth more than one saved from other illnesses?
James McGoram: Why medicine funding doesn't fit into the 'trolley problem' basket
Opinion: Saying some people are going to die is a failure of both empathy and imagination.
150 jobs going as pharma company closes Manukau site
Pharma company is closing sites in South Auckland that have operated since the 1990s.
Pharmac: Is our medicines agency still fit for purpose?
Agency's future is under scrutiny as it juggles public demands and rising drug prices.
Dying man's father hits out at Government funding gangs, not drugs
Justin Haigh is paying hundreds of thousands for unfunded, potentially life-saving drugs.
Pharmac releases priority funding lists for first time
The release comes after public pressure for the agency to be more transparent.
Access to miracle drug a 'lifeline' for cystic fibrosis patients with no hope
Drug company to fund miracle drug for those with CF who have exhausted all options.
Diabetes-drug decision will hit thousands, says doctor
Diabetes is the country's biggest and fastest-growing health condition.
Cecilia Robinson: Time to get serious about funding Pharmac
Pharmac now has more than $1 billion to spend every year, but it's nowhere near enough.
'Blood on my hands': Pharmac likely to end kids' cancer drug funding
Funding for drugs to help young cancer patients tipped to cease over "inconsistency".
Parents struggle to get support for daughter diagnosed with rare growth hormone disorder
Two-year-old Elenna suffers from a rare growth hormone disorder, so rare that there is no official name for it, which means no funding for drugs that can treat the condition. Video / Mark Mitchell
'I feel validated': Woman speaks after losing two babies due to 'incompetent' GP
'I had to bury two children and that's something that I don't think I will ever get over.'
Focus Live: Pharmac review to focus on speed and transparency
A review of the government's drug buyer Pharmac will focus on the timeliness and transparency of its decisions.
Dr Gary Payinda: 'If you don't want the jab, don't get it. Just stay away from patients'
Opinion: To provide a safety blanket, we need near-total coverage, with few exceptions.
Editorial: First vaccine passes muster and readied for rollout
EDITORIAL: Rollout to frontline workers and household contacts expected in first quarter.
Covid vaccine plant evacuated as company feuds with EU
AstraZeneca vaccine plant in Wales evacuated over a suspicious package.
Covid-19: WHO blasts vaccine profits and priorities
Director-General claims vaccine makers targeting locations where 'profits are highest'.
Reporter who covered Martin Shkreli arrest reveals relationship with him
New York Times: A reporter who covered Shkreli's arrest fell in love with him soon after.
AstraZeneca to buy Alexion in US$39b immunology deal
FTSE100 pharma giant says buying US rival will enhance its presence in immunology.
G20 leaders urge united response to virus
Covid-19 offers G20 members chance to cooperate for greater good - but will they?
Who will be first in line for the Pfizer Covid-19 vaccine?
Vulnerable people and frontline Covid-19 workers will be first up for the vaccine.